Miranda, M B <br/><br/>
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.  [electronic resource] 

 -  Leukemia  06 2016 
 - 1255-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2016.20  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Colorectal Neoplasms--chemically induced<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate--adverse effects<br/>Incidence<br/>Interferon-alpha--therapeutic use<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--complications<br/>Lymphoma, Non-Hodgkin--chemically induced<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--chemically induced<br/>Protein Kinase Inhibitors--adverse effects<br/>Sex Factors